GHK-Cu 100mg $79.00 GHK-Cu is a glycyl-L-histidyl-L-lysine tripeptide-copper complex with three decades of published research on skin biology, collagen and elastin synthesis, wound healing, gene expression, and hair follicle activity
Presented at the European Academy of Neurology Congress in Helinski, Finland, on June 21, the results suggest promising future uses of the popular obesity and diabetes drugs
Deoxycholic acid, for example, signals through TGR5, leading to PKA inhibition and has been linked to EGFR activation, ERK1/2 signaling, and occludin redistribution in Caco-2 cells (57, 58)
Synthetic analogs reproduce this signal with optimized pharmacokinetic profiles: Sermorelin (GRF 1-29): shortest active fragment, half-life ~10 minutes, signal close to natural Tesamorelin : analog stabilized by an N-terminal trans-3-hexenoyl group, half-life ~26 minutes, only molecule of the family with FDA approval (HIV-associated lipodystrophy reduction) CJC-1295 with DAC : Drug Affinity Complex modification that binds plasma albumin, extending half-life to ~8 days and creating continuous "GH bleed" rather than a pulse Key point: GHRH analogs preserve physiological pulsatility
Its primary function involves safeguarding the gastrointestinal lining, promoting healing processes, and fostering the growth of blood vessels
